Hims & Hers' strong Q3 results and 77% y/y revenue growth demonstrate ... It's worth noting as well that more than half of ...

If you’re looking to prevent hair loss or stop the progression of any hair loss that’s started, a topical product can help.

Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today announced financial results for the third quarter ended September 30, 2024 in a ...

The continued solid uptake of Hims & Hers offerings and expanding subscriber base are likely to have driven the company's ...

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) shares were down 5.4% during trading on Wednesday following insider selling activity. The company traded as low as $19.80 and last traded at $21.

Here are the best products available to encourage hair regrowth, including budget and over-the-counter options, subscriptions, shampoos, supplements, and more. Hims Topical Finasteride & Minoxidil ...

Lilly last week reported a rare $1.5 billion sales miss for its injectable obesity drug Zepbound and diabetes medicine Mounjaro combined, raising concerns among investors that demand might be cooling ...

Hims & Hers Health Inc. said an analysis of more than 10,000 patients taking a copycat version of Novo Nordisk A/S’s Ozempic and Wegovy showed the shot was a safe and effective way to shed pounds.

Lilly last week reported a rare $1.5 billion sales miss for its injectable obesity drug Zepbound and diabetes medicine ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.